Dr Daniel Garama is the Head of Proteomics at Hudson Institute of Medical Research. He has dedicated his career to the use of protein chemistry and proteomic approaches to elucidate and understand fundamental biological mechanisms that lead to clinical and commercial outcomes. He specialises in proteomic techniques, particularly the design and use of mass spectrometry to identify protein interactions, function and post translational modifications. Dr Garama has over 15 years of experience in this field, and has undertaken training at specialist international facilities to become an expert in both qualitative and quantitative techniques, along with specialist training in native-MS, hydrogen-deuterium exchange-MS, label free-MS, lipidomic and post translational modification analysis.
His current research interest surrounds mitochondrial proteomics, particularly those involved in mitochondrial biogenesis and the import, modification and interactions of non-MTS tagged proteins into the mitochondria. Dr Garama is an affiliate member and adviser at the Bio21 Mass Spectrometry and Proteomics Facility (MSPF), Melbourne University and also at Monash University.